Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Han

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
Transplant Infectious Disease : an Official Journal of the Transplantation Society|August 20, 2022
Impact of deceased organ donor injection drug use on donor culture positivity and recipient outcomesKrista Moore, Ebbing Lautenbach, Emily A Blumberg, et al.
Pediatric Blood & Cancer|May 26, 2018
Myeloid lineage switch following chimeric antigen receptor T-cell therapy in a patient with TCF3-ZNF384 fusion-positive B-lymphoblastic leukemiaMatthew J Oberley, Paul S Gaynon, Deepa Bhojwani, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 20, 2021
Antibiotic Utilization in Deceased Organ DonorsJudith A Anesi, Ebbing Lautenbach, Jennifer Han, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 9, 2025
Optical genome mapping improves clinical interpretation of constitutional copy number gains and reduces their VUS burdenAvinash V Dharmadhikari, Alexander L Markowitz, Jennifer Han, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 25, 2024
Impact of deceased organ donor marijuana use on donor culture positivity and solid organ transplant recipient outcomesKrista Moore, Ebbing Lautenbach, Emily A Blumberg, et al.
The Journal of Infectious Diseases|May 14, 2024
The Effect of Gastrointestinal Graft-Versus-Host Disease and Diarrhea on the Pharmacokinetic Profile of Sotrovimab in Hematopoietic Stem Cell Transplant RecipientsJim Boonyaratanakornkit, Qianwen Wang, Ahmed Nader, et al.
Neuro-Oncology Pediatrics|April 14, 2026
FOXR2-activated CNS neuroblastoma: Characterized by variable structural disruption of the <i>FOXR2</i> regulatory region, recurrent copy number alterations, and elevated <i>FOXR2</i> expressionJianling Ji, Venkata Yellapantula, Dong Xu, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 9, 2020
Prognostic Testing and Treatment Patterns in Chronic Lymphocytic Leukemia in the Era of Novel Targeted Therapies: Results From the informCLL RegistryAnthony R Mato, Jacqueline C Barrientos, Nilanjan Ghosh, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 4, 2024
Development of Predictive Models to Inform a Novel Risk Categorization Framework for Antibiotic Resistance in Escherichia coli-Caused Uncomplicated Urinary Tract InfectionRyan K Shields, Wendy Y Cheng, Kalé Kponee-Shovein, et al.
Drugs in R&D|November 24, 2025
Safety, Tolerability, Pharmacokinetics, and Viral Pharmacodynamics of the Monoclonal Antibody Sotrovimab Administered via Intramuscular Injection in Participants with Early, Mild-to-Moderate COVID-19: A Randomized Clinical TrialAnil Gupta, Maria Teresa Perez-Rodríguez, Yaneicy Gonzalez-Rojas, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Transplant Infectious Disease : an Official Journal of the Transplantation Society|August 20, 2022
Impact of deceased organ donor injection drug use on donor culture positivity and recipient outcomesKrista Moore, Ebbing Lautenbach, Emily A Blumberg, et al.
Pediatric Blood & Cancer|May 26, 2018
Myeloid lineage switch following chimeric antigen receptor T-cell therapy in a patient with TCF3-ZNF384 fusion-positive B-lymphoblastic leukemiaMatthew J Oberley, Paul S Gaynon, Deepa Bhojwani, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 20, 2021
Antibiotic Utilization in Deceased Organ DonorsJudith A Anesi, Ebbing Lautenbach, Jennifer Han, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 9, 2025
Optical genome mapping improves clinical interpretation of constitutional copy number gains and reduces their VUS burdenAvinash V Dharmadhikari, Alexander L Markowitz, Jennifer Han, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 25, 2024
Impact of deceased organ donor marijuana use on donor culture positivity and solid organ transplant recipient outcomesKrista Moore, Ebbing Lautenbach, Emily A Blumberg, et al.
The Journal of Infectious Diseases|May 14, 2024
The Effect of Gastrointestinal Graft-Versus-Host Disease and Diarrhea on the Pharmacokinetic Profile of Sotrovimab in Hematopoietic Stem Cell Transplant RecipientsJim Boonyaratanakornkit, Qianwen Wang, Ahmed Nader, et al.
Neuro-Oncology Pediatrics|April 14, 2026
FOXR2-activated CNS neuroblastoma: Characterized by variable structural disruption of the <i>FOXR2</i> regulatory region, recurrent copy number alterations, and elevated <i>FOXR2</i> expressionJianling Ji, Venkata Yellapantula, Dong Xu, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 9, 2020
Prognostic Testing and Treatment Patterns in Chronic Lymphocytic Leukemia in the Era of Novel Targeted Therapies: Results From the informCLL RegistryAnthony R Mato, Jacqueline C Barrientos, Nilanjan Ghosh, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 4, 2024
Development of Predictive Models to Inform a Novel Risk Categorization Framework for Antibiotic Resistance in Escherichia coli-Caused Uncomplicated Urinary Tract InfectionRyan K Shields, Wendy Y Cheng, Kalé Kponee-Shovein, et al.
Drugs in R&D|November 24, 2025
Safety, Tolerability, Pharmacokinetics, and Viral Pharmacodynamics of the Monoclonal Antibody Sotrovimab Administered via Intramuscular Injection in Participants with Early, Mild-to-Moderate COVID-19: A Randomized Clinical TrialAnil Gupta, Maria Teresa Perez-Rodríguez, Yaneicy Gonzalez-Rojas, et al.
Pageof 6